ShockWave Medical shares slid -5.7% this evening. Here's what you need to know about the mid-capMedical instruments & supplies company:
-
ShockWave Medical has logged a -26.0% 52 week change, compared to 15.0% for the S&P 500
-
SWAV has an average analyst rating of buy and is -25.23% away from its mean target price of $284.89 per share
-
Its trailing earnings per share (EPS) is $6.37, which brings its trailing Price to Earnings (P/E) ratio to 33.4. The Health Care sector's average P/E ratio is 24.45
-
The company's forward earnings per share (EPS) is $4.4 and its forward P/E ratio is 48.4
-
The company has a Price to Book (P/B) ratio of 12.68 in contrast to the Health Care sector's average P/B ratio is 4.16
-
The current ratio is currently 7.2, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
SWAV has reported YOY quarterly earnings growth of 11.8% and gross profit margins of 0.9%
-
The company's free cash flow for the last fiscal year was $142.86 Million and the average free cash flow growth rate is 0.0%
-
ShockWave Medical's revenues have an average growth rate of 0.0% with operating expenses growing at -40.3%. The company's current operating margins stand at 25.4%